Syngene International Ltd

Syngene International Ltd share price gained 1.74% to Rs 366.0 after the company's net profit tanked by 457.78% to Rs 32.2 crore, while revenue from operations increased 13.14% to Rs 832.7 crore in Q3FY26 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 41159.89 crore, easing 4.19%. It has eased by 0.93% over last one week and eased lower by 2.37% in last one month while the market capitalization of Syngene International Ltd has slipped by 2.74% and 8.24% in the same period respectively. Profit before tax (PBT) of Syngene International Ltd stood at Rs 47.0 crore in Q3 FY26, tumbling by 44.84% year-on-year, and crashing by 344.79% quarter-on-quarter. EBITDA came in at Rs 119 crore, plunging by 35.14% YoY and rallying 82.29% sequentially. Total expenses saw a slight increase of 5.23% to Rs 797.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 203.0 crore, going up by 13.92% YoY, while employee benefits expense was at Rs 272.7 crore, ticking higher by 0.59% YoY. For the TTM ended FY26, revenue from operations tick up 2.64% to Rs 3738.7 crore, while net profit tumbled by 36.17% to Rs 316.7 crore, compared to previous TTM. EBITDA surged by 98930% to Rs 847.8 crore, and PBT collapsed by 37.73% to Rs 410.9 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 915.2 crore in FY26, as against Rs 1167.6 crore in FY25. Syngene International Ltd crashed 44.57% in last one year, underperforming the benchmark BSE Sensex which has reduced by 13.19% during the same period.

Syngene International Ltd share price ticked higher by 1.74% to Rs 366.0 after the company's net profit witnessed a sharp fall of 457.78% to Rs 32.2 crore, while revenue from operations edged up 13.14% to Rs 832.7 crore in Q3FY26 over Q2FY26. The market capitalization of Healthcare Research, Analytics & Technology industry group stocks on BSE stood at Rs 42333.77 crore, rising 4.19%. It has softened by 4.40% over last one week and dipped slightly by 5.08% in last one month while the market capitalization of Syngene International Ltd has eased by 7.96% and 11.52% in the same period respectively. Profit before tax (PBT) of Syngene International Ltd stood at Rs 47.0 crore in Q3 FY26, tanking 44.84% year-on-year, and tumbling by 344.79% quarter-on-quarter. EBITDA came in at Rs 119 crore, nosediving by 35.14% YoY and jumping 82.29% sequentially. Total expenses posted a minor rise of 5.23% to Rs 797.0 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 203.0 crore, advancing by 13.92% YoY, while employee benefits expense was at Rs 272.7 crore, ticking higher by 0.59% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 2.64% to Rs 3738.7 crore, while net profit tanked by 36.17% to Rs 316.7 crore, compared to previous TTM. EBITDA soared by 98930% to Rs 847.8 crore, and PBT collapsed by 37.73% to Rs 410.9 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 915.2 crore in FY26, as against Rs 1167.6 crore in FY25. Syngene International Ltd nosedived by 45.51% in last one year, underperforming the benchmark BSE Sensex which has declined by 13.18% during the same period.

Syngene International Limited announced changes to its management team, including Subhendu Kumar and Priyaranjan Pattanaik transitioning from Senior Management Personnel (SMP) to Non-SMP categories effective October 27, 2026. Additionally, Ajay Tandon, Head of Strategy & Corporate Development, will resign on October 30, 2026, and Deepak Jain, Chief Financial Officer and Key Managerial Personnel, will be leaving the company to pursue opportunities outside Syngene, with a transition timeline to be mutually agreed upon.

Syngene International Limited informed the BSE Limited and National Stock Exchange of India Limited that details of securities dematerialized during the quarter ended September 30, 2026, have been furnished to stock exchanges, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, with a certificate from KFin Technologies Limited confirming the information dated October 6, 2026.

Syngene International Limited will hold a board meeting on Tuesday, October 27, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2026, and will host a conference call for analysts and investors on Wednesday, October 28, 2026. Trading in the company's securities will be restricted for insiders from October 1, 2026, until the close of trading hours on October 29, 2026.

Syngene International Limited will close its trading window for securities from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s code of conduct.

Syngene International Limited announced an investment of Rs 25.20 crore in Ampin C&I Power Twelve Private Limited to acquire a 12.44% stake, representing 25,20,000 equity shares at Rs 10 per share, with the allotment expected within 30 days. The acquisition, which does not constitute a related-party transaction, will enable Syngene to enhance renewable power consumption, reduce energy costs, and advance its decarbonization goals, aligning with the company’s renewable energy objectives.

Net loss of Syngene International reported to Rs 9.00 crore in the quarter ended June 2026 as against net profit of Rs 86.70 crore during the previous quarter ended June 2025. Sales declined 15.84% to Rs 736.00 crore in the quarter ended June 2026 as against Rs 874.50 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales736.00874.50 -16 OPM %12.3423.60 - PBDT106.50212.50 -50 PBT-5.70101.30 PL NP-9.0086.70 PL Powered by Capital Market - Live

Earnings before interest and taxes (EBIT) and profit before tax (PBT) generally increased between Q4 FY24 and Q3 FY26, though revenue growth appears to be slowing, according to recently released financial data. The company reported EBIT of 1,129 million INR in Q4 FY24, rising to 1,129 million INR in Q3 FY26. However, exceptional items significantly impacted profitability in several periods, including a 579 million INR negative impact in Q3 FY26 due to write-offs, the impact of new labor codes, and termination benefits. The acquisition of a biologics site in the USA in Q3 FY25 resulted in increased depreciation, and the company is navigating the complexities of new labor regulations, which initially resulted in a larger-than-anticipated impact. Further investigation is warranted into revenue drivers, acquisition integration, and the ongoing implications of the labor code changes.

Syngene International will hold a meeting of the Board of Directors of the Company on 29 July 2026.